Skip to content

Clinical trials

Lung Neoplasms trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Mexico Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20062
20071
20082
20092
20103
20122
20131
20141
20153
20162
20184
20192
20203
20211
20222
20235
20245
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting15
Active, not recruiting8
Terminated3
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Instituto Nacional de Cancerologia de Mexico10
Bristol-Myers Squibb5
AstraZeneca3
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
Amgen2
Eli Lilly and Company2
Genzyme, a Sanofi Company2
National Institute of Cancerología2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms50
Carcinoma, Non-Small-Cell Lung30
Neoplasm Metastasis7
Neoplasms5
Small Cell Lung Carcinoma4
Carcinoma3
Lung Diseases3
Adenocarcinoma of Lung2
Breast Neoplasms2
Carcinoma, Bronchogenic2

Trials

Showing 26 to 50 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.